Measles is rightly called as captain of killer team in India. We used
to see measles cases mostly between 1 to 3 years of age group and
mumps in school going children. Morbidity due to measles and mumps is
very well known. Nowadays there is distinct change in the measles and
mumps disease pattern due to measles and MMR vaccination. Both these
vaccine were supposed to offer lifelong immunity to the children. But
now-a-days we see measles in 7 to 10 years age group children who
received only measles vaccine by 9 months of age. Those children who
received both measles and MMR vaccines, contracted measles and/or
mumps by 12 to 15 years so it is obvious from our field experience
that measles vaccines immunity wanes away by 7 to 8 years of age and
when both measles and MMR vaccines are given to the children according
to our IAP schedule(1) immunity against measles and mumps lasts up to
12 to 15 years of age. Mumps was the disease of school going children,
but now we see mumps patients in much older age group children. So
introduction of MMR is very useful, but it falls short of our
expectation. Therefore, why not give booster dose of MMR say by 10
years of age? There is a strong recommendation of rubella vaccine in
adolescent girls. But why only rubella? Measles, mumps are also
troubling our adolescents. If we start repeating booster dose of MMR
vaccine, say by 10 years of age, then there is no need of rubella
vaccination as well. The immunity from MMR lasts for 10-15 yrs of age.
Then a booster dose at 10 years of age will give a life long immunity.
Our children should not suffer from measles, mumps and rubella during
the crucial period of their life is the thought behind this
communication.
While going through the literature it was found
that American Academy of Pediatrics and most of the western countries
are following the revaccination schedule since 1989(2-4). They are
revaccinating their children either by 5 years of age or when they
become adolescents. IAP has not recommended a booster dose of MMR
vaccine. This is because routine coverage by measles and MMR vaccine
is poor. Therefore naturally occurring sub clinical measles, mumps and
rubella are common which act like a natural booster in vaccinees. In
future high percentage of immunization amongst our people will take
away the advantage of natural sub clinical infections and then second
dose of MMR may be considered.
Our experience is not in favor of these natural sub
clinical infections working as booster doses. There are so many grown
up adolescents we see suffering from full-blown picture of measles or
mumps. Our appeal to IAP is kindly give due consideration to recommend
the booster dose of MMR vaccine at 10 years of age.
Vinayak Deshmukh,
Jawahar Lal Nehru Medical College,
Sawangi Meghe, Wardha 442 002,
Maharashtra,
India.
E-mail:
[email protected]
1. Recommendation. In: Dubey AP, Surjit S,
editors. IAP Guidebook on Immunization, 3rd edn. New Delhi: IAP
Committee on Immunication, p. 17-19.
2. Johnson CE, Kumar ML, Whitwell JK, Staehle BO,
Rome LP, Dinkar C, et al. Antibody persis-tence after primary
measles-mumps-rubella vaccine and response to second dose given at
four to six vs eleven to thirteen years. Pediatr Infect Dis J 1996;
15: 687-692.
3. Davidkin I, Peltola H, Leinikki P,Valle M. Duration of rubella
immunity by two-dose measles, mumps, rubella (MMR) vaccine. A 15
year follow up in Finland. Vaccine2000; 18: 3106-3112.
4. Cote TR, Sivertson D, Horan JM, Lindegren ML, Dwyer DM.
Evaluation of two doses of measles,mumps and rubella vaccination
schedule in a cohort of college athletes. Public Health Resp 1993;
4: 431-435.